2015, the FDA released a pair of draft “guidance” documents on “Adaptive Design” clinical trials for drugs and medical devices,
If the fda is moving towards innovative trial designs, it suggests that drs should consider new drugs rather than relying soley on traditional options potentially leading to better outcomes for patients.
